Latest Blogs

Aug 09, 2018
"You're an oncologist? How can you do it?" Radiation oncologists chimed in on Twitter about the rewards of the job.
Aug 08, 2018
Dr. Raj Mohan looks at surgical oncology through the lens of the saying that "the proof of the pudding is in the eating": ultimately, the outcome matters more than the process.
Aug 07, 2018
I spoke with our current ASCO president about her theme for the year, her work with the Alliance for Clinical Trials in Oncology, and her frontier spirit.
Aug 06, 2018
A patient who refused chemotherapy offered Dr. Erika Hamilton a lesson in compromise. 
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Aug 05, 2015
Looking back on the 1976 Bonadonna study using CMF chemotherapy in women with breast cancer and positive axillary nodes, I consider what went wrong in the search for similarly effective treatment of prostate cancer.
Jun 03, 2015
As someone who is interested in prostate cancer almost exclusively in my practice, listening to Dr. Nicholas James present the data from the STAMPEDE trial was of high interest.
May 31, 2015
I listened to some of my favorite presenters in my field of interest and got to sample some wonderful biology I would most certainly have missed.
May 30, 2015
I think I may have absorbed more information in this format than the usual scurrying about in Chicago, and my own bed was terrific.
May 26, 2015
This year, I plan to follow the ASCO Annual Meeting from the comfort of my home. It will be the first year of “missing” the Annual Meeting, and one question is whether I will have the discipline to watch enough presentations to feel like I have been sufficiently updated.
Apr 30, 2015
For the past month or so, one patient after another has come in with the question, “So, what do you think about 4-MU?” or “Did you hear about poliovirus killing cancer?” Actually, I have heard next to nothing about either, but of course I was intrigued as to where my patients get their information.

Pages